CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 91 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 3.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $292,000 | -63.9% | 58,500 | -8.6% | 0.00% | -100.0% |
Q4 2020 | $809,000 | +26.4% | 63,973 | -1.8% | 0.00% | 0.0% |
Q3 2020 | $640,000 | +1.4% | 65,173 | +2.8% | 0.00% | 0.0% |
Q2 2020 | $631,000 | -5.7% | 63,373 | -16.3% | 0.00% | 0.0% |
Q1 2020 | $669,000 | -38.6% | 75,689 | -35.9% | 0.00% | 0.0% |
Q4 2019 | $1,089,000 | +19.9% | 118,100 | -23.6% | 0.00% | 0.0% |
Q3 2019 | $908,000 | -48.2% | 154,500 | +5.8% | 0.00% | -50.0% |
Q2 2019 | $1,752,000 | -2.6% | 146,000 | -2.1% | 0.00% | 0.0% |
Q1 2019 | $1,799,000 | +60.6% | 149,079 | +67.0% | 0.00% | 0.0% |
Q4 2018 | $1,120,000 | -10.7% | 89,279 | +5.7% | 0.00% | 0.0% |
Q3 2018 | $1,254,000 | -15.4% | 84,479 | -4.1% | 0.00% | 0.0% |
Q2 2018 | $1,482,000 | -23.9% | 88,079 | +3.6% | 0.00% | -33.3% |
Q1 2018 | $1,947,000 | -11.5% | 85,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $2,199,000 | +75.4% | 85,000 | 0.0% | 0.00% | +50.0% |
Q3 2017 | $1,254,000 | +5.7% | 85,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $1,186,000 | -18.2% | 85,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,450,000 | +65.7% | 85,000 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $875,000 | +1.9% | 85,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $859,000 | -10.1% | 85,000 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $955,000 | -17.7% | 85,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $1,161,000 | -41.0% | 85,000 | -18.0% | 0.00% | -33.3% |
Q4 2015 | $1,967,000 | +23.3% | 103,700 | +22.0% | 0.00% | 0.0% |
Q3 2015 | $1,595,000 | +26.0% | 85,000 | 0.0% | 0.00% | +50.0% |
Q2 2015 | $1,266,000 | +7.2% | 85,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $1,181,000 | 0.0% | 85,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,181,000 | +10.2% | 85,000 | 0.0% | 0.00% | +100.0% |
Q3 2014 | $1,072,000 | +24.8% | 85,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $859,000 | -15.8% | 85,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $1,020,000 | – | 85,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |